Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Lidia Rita Corsini, Daniele Fanale, Francesco Passiglia, Lorena Incorvaia, Vincenzo Gennusa, Viviana Bazan & Antonio Russo. (2018) Monoclonal antibodies for the treatment of non-hematological tumors: a safety review. Expert Opinion on Drug Safety 17:12, pages 1197-1209.
Read now
Read now
Articles from other publishers (28)
Yihua Liu, Li Zheng, Xingjuan Cai, Xiaojun Zhang & Yang Ye. (2023) Cardiotoxicity from neoadjuvant targeted treatment for breast cancer prior to surgery. Frontiers in Cardiovascular Medicine 10.
Crossref
Crossref
Wei Liu, Wei Li, Hairu Li, Ziyao Li, Peng Zhao, Zihong Guo, Cong Liu, Litao Sun & Zhenzhen Wang. (2022) Two-dimensional speckle tracking echocardiography help identify breast cancer therapeutics–related cardiac dysfunction. BMC Cardiovascular Disorders 22:1.
Crossref
Crossref
Jean C. Bikomeye, Janée D. Terwoord, Janine H. Santos & Andreas M. Beyer. (2022) Emerging mitochondrial signaling mechanisms in cardio-oncology: beyond oxidative stress. American Journal of Physiology-Heart and Circulatory Physiology 323:4, pages H702-H720.
Crossref
Crossref
Layla Al-mansoori, Philip Elsinga & Sayed K. Goda. (2021) Bio-vehicles of cytotoxic drugs for delivery to tumor specific targets for cancer precision therapy. Biomedicine & Pharmacotherapy 144, pages 112260.
Crossref
Crossref
Justin A. Veeder, Lauren N. Hothem, Amber E. Cipriani, Brian C. Jensen & Jo E. Rodgers. (2021) Chemotherapy‐associated cardiomyopathy: Mechanisms of toxicity and cardioprotective strategies. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 41:12, pages 1066-1080.
Crossref
Crossref
George Koulaouzidis, Amanda E. Yung, Diana E. Yung, Karolina Skonieczna-Żydecka, Wojciech Marlicz, Anastasios Koulaouzidis & Dafni Charisopoulou. (2021) Conventional cardiac risk factors associated with trastuzumab-induced cardiotoxicity in breast cancer: Systematic review and meta-analysis. Current Problems in Cancer 45:5, pages 100723.
Crossref
Crossref
Miguel Anjos, Marta Fontes-Oliveira, Vera M. Costa, Mário Santos & Rita Ferreira. (2021) An update of the molecular mechanisms underlying doxorubicin plus trastuzumab induced cardiotoxicity. Life Sciences 280, pages 119760.
Crossref
Crossref
Naomi Dempsey, Amanda Rosenthal, Nitika Dabas, Yana Kropotova, Marc Lippman & Nanette H. Bishopric. (2021) Trastuzumab-induced cardiotoxicity: a review of clinical risk factors, pharmacologic prevention, and cardiotoxicity of other HER2-directed therapies. Breast Cancer Research and Treatment 188:1, pages 21-36.
Crossref
Crossref
José Isaac Alves de Andrade, Daniel Pinheiro Fernandes, Ingrid Yanne Gomes Ferreira, Letícia Rodrigues de Abrantes & Danielle Rocha Silva. (2020) ESTUDO DA CARDIOTOXICIDADE INDUZIDA PELO TRASTUZUMAB NA TERAPIA DO CÂNCER DE MAMA HER2 POSITIVO. Revista interdisciplinar em saúde 7:Único, pages 620-635.
Crossref
Crossref
Heather S. Laird-Fick, Hemasri Tokala, Samanjit Kandola, Michael Kehdi, Augusta Pelosi, Ling Wang & Brian Grondahl. (2020) Early morphological changes in cardiac mitochondria after subcutaneous administration of trastuzumab in rabbits: possible prevention with oral selenium supplementation. Cardiovascular Pathology 44, pages 107159.
Crossref
Crossref
Dorothy M K Keefe & Emma H Bateman. (2019) Potential Successes and Challenges of Targeted Cancer Therapies. JNCI Monographs 2019:53.
Crossref
Crossref
Wenjie Xu, Yizhen Wang, Yanan Wang, Shanmei Lv, Xiuping Xu & Xuejun Dong. (2019) Screening of differentially expressed genes and identification of NUF2 as a prognostic marker in breast cancer. International Journal of Molecular Medicine.
Crossref
Crossref
Xuguang Hu, Dan Ding, Jiayi Zhang & Jianguo Cui. (2019) Knockdown of lncRNA HOTAIR sensitizes breast cancer cells to ionizing radiation through activating miR-218. Bioscience Reports 39:4.
Crossref
Crossref
Amy A. Kirkham, Rhys I. Beaudry, D. Ian Paterson, John R. Mackey & Mark J. Haykowsky. (2019) Curing breast cancer and killing the heart: A novel model to explain elevated cardiovascular disease and mortality risk among women with early stage breast cancer. Progress in Cardiovascular Diseases 62:2, pages 116-126.
Crossref
Crossref
Thalita Basso Scandolara, Bruno Ricardo Pires, Rodrigo Kern, Vanessa Jacob Victorino & Carolina Panis. 2019. Oxidative Stress in Heart Diseases. Oxidative Stress in Heart Diseases
39
57
.
Zhong-Feng Wang, Wen-Yi Sun, De-Hai Yu, Yan Zhao, Hong-Mei Xu, Yu-Fang He & Hai-Jun Li. (2018) Rotundic acid enhances the impact of radiological toxicity on MCF-7 cells through the ATM/p53 pathway. International Journal of Oncology.
Crossref
Crossref
Taylor A. JohnsonDinender K. Singla. (2018) Breast cancer drug trastuzumab induces cardiac toxicity: evaluation of human epidermal growth factor receptor 2 as a potential diagnostic and prognostic marker. Canadian Journal of Physiology and Pharmacology 96:7, pages 647-654.
Crossref
Crossref
Junjie Piao, Liyan Chen, Tiefeng Jin, Ming Xu, Chunji Quan & Zhenhua Lin. (2018) Paip1 affects breast cancer cell growth and represents a novel prognostic biomarker. Human Pathology 73, pages 33-40.
Crossref
Crossref
Chrisandra L. Shufelt, Christine Pacheco, Marysia S. Tweet & Virginia M. Miller. 2018. Sex-Specific Analysis of Cardiovascular Function. Sex-Specific Analysis of Cardiovascular Function
433
454
.
Xiao Wu, Meng-Yao Wu, Min Jiang, Qiaoming Zhi, Xiaojie Bian, Meng-Dan Xu, Fei-Ran Gong, Juan Hou, Min Tao, Liu-Mei Shou, Weiming Duan, Kai Chen, Meng Shen & Wei Li. (2017) TNF-α sensitizes chemotherapy and radiotherapy against breast cancer cells. Cancer Cell International 17:1.
Crossref
Crossref
Chit Tam, Jack Ho Wong, Randy Chi Fai Cheung, Tao Zuo & Tzi Bun Ng. (2017) Therapeutic potentials of short interfering RNAs. Applied Microbiology and Biotechnology 101:19, pages 7091-7111.
Crossref
Crossref
Götz Pilarczyk, Ines Nesnidal, Manuel Gunkel, Margund Bach, Felix Bestvater & Michael Hausmann. (2017) Localisation Microscopy of Breast Epithelial ErbB-2 Receptors and Gap Junctions: Trafficking after γ-Irradiation, Neuregulin-1β, and Trastuzumab Application. International Journal of Molecular Sciences 18:2, pages 362.
Crossref
Crossref
Shahryar Khoshtinat Nikkhoi, Fatemeh Rahbarizadeh & Davoud Ahmadvand. (2017) Oligo-clonal nanobodies as an innovative targeting agent for cancer therapy: New biology and novel targeting systems. Protein Expression and Purification 129, pages 115-121.
Crossref
Crossref
A. Lajoie, J. Dunhill & M.A. Hamilton. 2017. Cardio-Oncology. Cardio-Oncology
297
307
.
Meidi Yan, Lina Zhang, Guoqing Li, Shengwen Xiao, Ji Dai & Xueying Cen. (2017) Long noncoding RNA linc-ITGB1 promotes cell migration and invasion in human breast cancer. Biotechnology and Applied Biochemistry 64:1, pages 5-13.
Crossref
Crossref
Francesca De Iuliis, Gerardo Salerno, Ludovica Taglieri, Luciano De Biase, Rosina Lanza, Patrizia Cardelli & Susanna Scarpa. (2015) Serum biomarkers evaluation to predict chemotherapy-induced cardiotoxicity in breast cancer patients. Tumor Biology 37:3, pages 3379-3387.
Crossref
Crossref
Paolo Giorgini, Davide Grassi, Paolo Di Giosia & Claudio Ferri. (2016) Exercise training improves cardiopulmonary and endothelial function in women with breast cancer: findings from the Diana-5 study. Internal and Emergency Medicine 11:2, pages 171-173.
Crossref
Crossref
Mariam Jafri & Daniel Rea. (2016) Cardiac safety of simultaneous anti-HER2 and anthracycline therapy. Breast Cancer Management 5:1, pages 21-29.
Crossref
Crossref